Profile data is unavailable for this security.
About the company
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
- Revenue in USD (TTM)0.00
- Net income in USD-6.91m
- Incorporated2013
- Employees3.00
- LocationGalmed Pharmaceuticals Ltd16 Tiomkin StreetTEL AVIV-YAFO 6578317IsraelISR
- Phone+972 36938448
- Fax+972 36938447
- Websitehttps://www.galmedpharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Panbela Therapeutics Inc | 0.00 | -27.26m | 1.94m | 7.00 | -- | -- | -- | -- | -20.38 | -20.38 | 0.00 | -0.6563 | 0.00 | -- | -- | 0.00 | -201.94 | -215.89 | -809.38 | -476.38 | -- | -- | -- | -- | -- | -161.79 | 4.16 | -- | -- | -- | 27.68 | -- | -- | -- |
| Twinlab Consolidated Holdings Inc | 12.65m | -9.55m | 1.94m | 17.00 | -- | -- | -- | 0.1537 | -0.0369 | -0.0502 | 0.0488 | -0.5447 | 1.01 | 1.49 | 7.30 | 743,941.20 | -76.13 | -60.53 | -- | -- | 34.59 | 21.36 | -75.51 | -37.72 | 0.0094 | -0.0108 | -- | -- | -20.87 | -28.58 | -20.28 | -- | -- | -- |
| VG Life Sciences Inc | 0.00 | -4.30m | 2.11m | 7.00 | -- | -- | -- | -- | -0.0721 | -0.0721 | 0.00 | -0.0491 | 0.00 | -- | -- | -- | -384.41 | -294.08 | -- | -- | -- | -- | -- | -587,591.90 | -- | -1.70 | -- | -- | -- | -- | 16.58 | -- | -- | -- |
| America Great Health | 219.13k | -859.20k | 2.11m | 7.00 | -- | -- | -- | 9.64 | -0.00004 | -0.00004 | 0.00001 | -0.0002 | 0.6746 | 0.0721 | 18.16 | 31,304.29 | -265.62 | -543.96 | -- | -- | 95.92 | -247.36 | -393.74 | -1,193.55 | 0.035 | -1.37 | -- | -- | 95.23 | -- | 84.35 | -- | -- | -- |
| Windtree Therapeutics Inc | 0.00 | -5.96m | 2.11m | 15.00 | 0.1927 | 0.1181 | -- | -- | 18.53 | 18.53 | 0.00 | 30.23 | 0.00 | -- | -- | 0.00 | -18.26 | -44.51 | -20.72 | -48.38 | -- | -- | -- | -94,533.34 | -- | -- | 0.00 | -- | -- | -- | 48.25 | -- | -- | -- |
| Link Reservations Inc | 0.00 | -480.90k | 2.11m | 0.00 | -- | -- | -- | -- | -46.51 | -46.51 | 0.00 | -13.99 | 0.00 | -- | -- | -- | -246.84 | -- | -- | -- | -- | -- | -- | -- | -- | -2.43 | -- | -- | -- | -- | -22.69 | -- | -- | -- |
| CYANOTECH CORP | 22.49m | -4.62m | 2.12m | 86.00 | -- | 0.1518 | -- | 0.0941 | -0.7265 | -0.7265 | 3.53 | 2.01 | 0.7889 | 1.53 | 10.73 | 261,546.50 | -16.19 | -2.32 | -21.07 | -2.96 | 29.59 | 35.88 | -20.52 | -2.33 | 0.3702 | -5.93 | 0.3299 | -- | -35.56 | -7.44 | -259.70 | -- | 1.22 | -- |
| American Green Inc | -100.00bn | -100.00bn | 2.14m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Salarius Pharmaceuticals Inc | 0.00 | -8.92m | 2.21m | 2.00 | -- | 0.5476 | -- | -- | -2.71 | -2.71 | 0.00 | 0.8459 | 0.00 | -- | -- | 0.00 | -119.38 | -69.27 | -193.68 | -79.89 | -- | -- | -- | -675.70 | -- | -- | 0.031 | -- | -- | -- | 60.32 | -- | -- | -- |
| Galmed Pharmaceuticals Ltd | 0.00 | -6.91m | 2.22m | 3.00 | -- | 0.1345 | -- | -- | -3.68 | -3.68 | 0.00 | 2.75 | 0.00 | -- | -- | 0.00 | -41.65 | -45.06 | -50.55 | -50.79 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.31 | -- | -- | -- |
| Aclarion Inc | 60.05k | -6.13m | 2.46m | 6.00 | -- | 0.8566 | -- | 40.98 | -7.41 | -7.41 | 0.0341 | 0.3502 | 0.0215 | -- | 3.50 | 10,008.33 | -219.26 | -- | -337.53 | -- | -29.49 | -- | -10,203.20 | -- | -- | -- | 0.211 | -- | 24.75 | -- | 34.38 | -- | -- | -- |
| InMed Pharmaceuticals Inc | 5.63m | -6.08m | 2.47m | 13.00 | -- | 0.1686 | -- | 0.4383 | -1.23 | -1.23 | 0.9284 | 1.75 | 0.4006 | 2.71 | 29.77 | -- | -43.26 | -88.10 | -50.03 | -104.19 | 39.20 | -- | -108.01 | -1,066.11 | 5.80 | -- | 0.00 | -- | 279.60 | -- | 57.27 | -- | 29.56 | -- |
| Agile Therapeutics Inc | 21.50m | -7.79m | 2.48m | 19.00 | -- | -- | -- | 0.1152 | -3.65 | -3.65 | 6.98 | -1.51 | 1.63 | 2.90 | 5.42 | 1,131,316.00 | -59.25 | -94.24 | -- | -142.62 | 59.73 | -- | -36.26 | -513.50 | 0.3843 | -- | -- | -- | 80.02 | -- | 43.08 | -- | -- | -- |
| Mustang Bio Inc | 0.00 | -40.10m | 2.52m | 80.00 | -- | -- | -- | -- | -4.55 | -4.55 | 0.00 | -0.4757 | 0.00 | -- | -- | 0.00 | -90.93 | -70.02 | -138.05 | -79.98 | -- | -- | -- | -- | -- | -15.88 | -- | -- | -- | -- | 33.44 | -- | -60.75 | -- |
Data as of May 31 2024. Currency figures normalised to Galmed Pharmaceuticals Ltd's reporting currency: US Dollar USD
2.87%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Heights Capital Management, Inc.as of 31 Mar 2024 | 74.67k | 1.24% |
| Walleye Capital LLCas of 31 Mar 2024 | 42.01k | 0.70% |
| Two Sigma Advisers LPas of 31 Mar 2024 | 22.27k | 0.37% |
| Two Sigma Securities LLCas of 31 Mar 2024 | 16.31k | 0.27% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 13.26k | 0.22% |
| UBS Securities LLCas of 31 Mar 2024 | 2.26k | 0.04% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 1.24k | 0.02% |
| Wells Fargo Clearing Services LLCas of 31 Mar 2024 | 204.00 | 0.00% |
| TSFG LLCas of 31 Mar 2024 | 200.00 | 0.00% |
| Desjardins Securities, Inc.as of 31 Mar 2024 | 167.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
